Intron Health on Wednesday upgraded British pharmaceutical company GSK (GSK.L) to hold from sell and raised its price target to 20 pounds sterling from 19 pounds.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Nuvalent (NUVL) has an average rating of overweight and mean price target of $138.81, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $123.08, Change: $+34.59, Percent Change: +39.08%
Nuvalent (NUVL) has an average rating of overweight and mean price target of $138.81, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $122.87, Change: $+34.38, Percent Change: +38.85%
Nuvalent (NUVL) has an average rating of overweight and mean price target of $141.22, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)